Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFIBROTIDE vs DELORAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFIBROTIDE vs DELORAZEPAM: Safety Overview

Metric DEFIBROTIDE DELORAZEPAM
Total FAERS Reports 3,740 1,744
Deaths Reported 1,804 106
Death Rate 48.2% 6.1%
Hospitalizations 832 999
Average Patient Age 36.3 yrs 44.9 yrs
% Female Patients 38.7% 63.9%
FDA Approval Date Mar 30, 2016 N/A
Manufacturer Jazz Pharmaceuticals, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A